Publicaciones Científicas
Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits
Autor/Autores: Elena Gómez de Barreda, Mar Pérez, Pilar Gómez Ramos, Javier de Cristobal, Patricia Martín-Maestro, Asunción Morán, Hana N. Dawson, Michael P. Vitek, José J. Lucas, Félix Hernández, Jesús AvilaSignatura: Neurobiology of Disease, Volume 37. Issue 3, March 2010, Pages 622-629
Neuronal in vitro models for the estimation of acute systemic toxicity
Autor/Autores: A. Forsby, A.K. Bal-Price, A. Camins, S. Coecke, N. Fabre, H. Gustafsson, P. Honegger, A. Kinsner-Ovaskainen, M. Pallas, V. Rimbau, E. Rodríguez-Farré, C. Suñol, J.A. Vericat, M.G. ZurichSignatura: Toxicology in Vitro, 2009, 23, 1564-1569
A novel GSK-3ß inhibitor reduces Alzheimer’s pathology and rescues neuronal loss in vivo.
Autor/Autores: L. Serenó, M. Coma, M. Rodríguez, P. Sánchez-Ferrer, M.B. Sánchez, I. Gich, J.M. Agulló, M. Pérez, J. Ávila, C. Guardia-Laguarta, J. Clarimón, A. Lleó, T. Gómez-Isla.Signatura: Neurobiology of Disease, Volume 35. Issue 3, September 2009, Pages 359-367
Tacrine–Melatonin Hybrids as Multifunctional Agents for Alzheimer’s Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties
Autor/Autores: María Isabel Fernández-Bachiller, Concepción Pérez, Nuria Eugenia Campillo, Juan Antonio Páez, Gema Cristina González-Muñoz, Paola Usán, Esther García-Palomero, Manuela G. López, Mercedes Villarroya, Antonio G. García, Ana Martínez and María Isabel Rodríguez-Franco.Signatura: ChemMedChem 2009, 4, 828-841
A d-Catenin Signaling Pathway Leading to Dendritic Protrusions.
Autor/Autores: Kawther Abu-Elneel, Tomoyo Ochiishi, Miguel Medina, Monica Remedi, Laura Gastaldi, Alfredo Caceres and Kenneth S. Kosik.Signatura: The Journal of Biological Chemistry, 2008, 283, 47, 32781-32791
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice
Autor/Autores: Angelo O. Rosa, Manuella P. Kaster, Ricardo W. Binfaré, Susana Morales, Ester Martín-Aparicio, Maria Luisa Navarro-Rico, Ana Martinez, Miguel Medina, Antonio G. García, Manuela G. López, Ana Lúcia S. Rodrigues.Signatura: Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2008, 32, 1549-1556
Therapeutic Potential of Potent Marine NeuroprotectansTherapeutic Potential of Potent Marine Neuroprotectans
Autor/Autores: E. García-Palomero, P. Usán, J. Pérez-Baz, R.I. Fernández, A. Martínez, A. Fernández and M. MedinaSignatura: New Trends in Alzheimer and Parkinson Related Disorder; ADPD 2007. Salzburg, Austria, March 14-18
Potent ß-Amyloid Modulators
Autor/Autores: Esther García-Palomero, Pilar Muñoz, Paola Usán, Pablo García, Elena Delgado, Celia De Austria, Rita Valenzuela, Laura Rubio, Miguel Medina, Ana Martínez.Signatura: Neurodegenerative Diseases, 2008, 5, 153-156
Glycogen Synthase Kinase 3 (GSK-3) as a Molecular Target for Alzheimer's Disease And Other Tauopathies
Autor/Autores: Miguel MedinaSignatura: In: Neurodegenerative Diseases: From Molecular Concepts… Editors: R. von Bernhardi et al., 2008, pp.93-110
Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic
Autor/Autores: Miguel Medina and Ana CastroSignatura: Curr. Opin. Drug Discov. Develop. 2008, 11, 4, 633-543
Dirección Postal:
Noscira, S.A.
Avda. de la Industria, 52
Tres Cantos 28760 - Madrid (España)
Direcciones de correo electrónico:
Administración y Servicios: noscira@noscira.com
Investigación: info_di@noscira.com
Comunicaciones:
Tel. +34 91 806 11 30
Fax. +34 91 803 46 60